Net Cash Provided by (Used in) Financing Activities in USD of Fortress Biotech, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Fortress Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Fortress Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $52.1M, a 87.2% increase year-over-year.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $70.6M, a 116% increase from 2023.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $32.7M, a 56.5% decline from 2022.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $75.3M, a 49.4% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Fortress Biotech, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $52.1M +$24.3M +87.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 $27.9M +$5.67M +25.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 $22.2M -$27.8M -55.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $50M -$28.7M -36.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $78.7M +$55.9M +246% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $22.8M -$29.4M -56.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $52.1M +$12.5M +31.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $39.7M -$18.5M -31.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $58.2M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2013 $11.3M Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-09

Fortress Biotech, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $70.6M +$37.9M +116% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $32.7M -$42.6M -56.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $75.3M -$73.7M -49.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $149M -$23.4M -13.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $172M +$25.7M +17.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $147M +$96.1M +190% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
2018 $50.6M -$99.7M -66.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $150M +$107M +250% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $42.9M -$18M -29.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $60.9M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2013 $89.2M +$48.6M +120% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-14
2012 $40.5M +$17.4M +75.4% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
2011 $23.1M +$4.05M +21.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $19M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.